Consumer prices in China rose during the month of November, remaining slightly above what markets had initially anticipated. However, the figure remained below the upper limit of the government’s target range.
China’s consumer price index (CPI) advanced 2.3 percent from a year ago, after climbing 2.1 percent in October, data released by the National Bureau of Statistics showed Friday. A median estimate of economists called for a 2.2 percent year-over-year gain.
Compared to October, consumer prices rose 0.1 percent, matching forecasts. That followed a 0.1 percent decline the previous month, the data showed.
Separately, the producer price index (PPI) soared 3.3 percent in the 12 months through November, well above forecasts calling for 2.2 percent. Producer inflation has now risen in each of the last three months after nearly five years of decline.
However, Beijing’s terms of trade improved in November, once again pointing to an industrial recovery. November imports expanded at the fastest pace in more than two years on strong commodity demand, especially for coal and iron ore.
Further, the Chinese economy is expected to benefit from the U.S. President-elect Trump’s victory in wake of the protectionist policies likely to be implemented by him.
Meanwhile, the USD/CNY traded at 6.89, up 0.28 percent.


Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Gold Prices Fall Amid Rate Jitters; Copper Steady as China Stimulus Eyed
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
UK Starting Salaries See Strongest Growth in 18 Months as Hiring Sentiment Improves
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



